Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Indication and important safety information INCRELEX (mecasermin) is indicated for the treatment of growth failure in pediatric patients aged 2 years and older with severe primary IGF-1 deficiency* (IGFD), or with hormone (GH) gene deletion who have developed neutralizing antibodies to GH
Third-party tested for quality and purity
Ed Engl
Rising intracellular calcium levels may drive the fusion of growth hormone-containing vesicles with the plasma membrane, facilitating the release of growth hormone into the extracellular environment
Non-normalized data sets from selected results are shown in Supplementary Fig
403: acute inhalation toxicity
US$ 28.93
US$ 25.62
US$ 26.34
